Back
Open Access

The burden of structural heart valve diseases - Incidence, Prevalence, Treatment Pathways, Quality of Care in the EU.

Session: Current minimally-invasive treatment modalities for heart valve diseases : what is next?
Topic: Treatment
Speaker: Professor B. Prendergast (London, GB)
Sponsored by Edwards Lifesciences
Event: ESC Congress 2018

Presentation

0

About the speaker

Professor Bernard David Prendergast

St Thomas' Hospital, London (United Kingdom of Great Britain & Northern Ireland)
19 presentations
3 followers

5 more presentations in this session

Introduction and learning objective - Current minimally-invasive treatment modalities for heart valve diseases: what is next?

Speaker: Professor M. Gilard (Brest, FR)

Access
Slides
Video
0
Thumbnail

What are current and future treatment modalities? A tailored approach - Aortic stenosis

Speaker: Professor H. Moellmann (Dortmund, DE)

Access
Slides
Video
0
Thumbnail

What are current and future treatment modalities? A tailored approach - Mitral regurgitation

Speaker: Doctor A. Latib (New York, US)

Access
Slides
Video
0
Thumbnail

What are current and future treatment modalities? A tailored approach - Tricuspid regurgitation

Speaker: Doctor M. Enriquez-Sarano (Minneapolis, US)

Access
Slides
Video
0
Thumbnail

Session key takeaways - Current minimally-invasive treatment modalities for heart valve diseases : what is next?

Speaker: Professor M. Gilard (Brest, FR)

Access
Slides
Video
0
Thumbnail

Access the full session

Current minimally-invasive treatment modalities for heart valve diseases : what is next?

Speakers: Professor B. Prendergast, Professor M. Gilard, Professor H. Moellmann, Doctor A. Latib, Doctor M. Enriquez-Sarano...
Access
0
Thumbnail

About the event

Image

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress
logo Image

This platform is supported by

logo Novo Nordisk